What is the dividend growth rate of CSL stock?

CSL's dividends are worth more than what meets the eye.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

CSL Ltd (ASX: CSL) may be the third-largest stock on the S&P/ASX 200 Index (ASX: XJO). But unlike most of its peers in the top echelons of the ASX 200, CSL is not well-known as a generous dividend payer. 

In fact, out of the ASX 200's top ten shares, CSL is currently one of only two shares that today offers a dividend yield of under 3% (the other being Goodman Group (ASX: GMG)).

However, this simple observation hides what has been a fairly compelling dividend growth story for CSL shares and their owners. So today, let's dive into the dividend growth history of the CSL share price.

Shot of a scientist using a computer while conducting research in a laboratory.

Image source: Getty Images

What is a dividend growth rate?

A dividend growth rate simply refers to the consistency and magnitude of a company's dividend growth over time. If a company pays out $1 per share in dividends in one year, but $1.10 in the next and $1.20 in the year after that, we can say it has an average dividend growth rate of 10% per annum.

Of course, many companies don't consistently grow their dividend every single year. Many, particularly cyclical shares like mining companies, adjust them from year to year based on how much profits they are raking in.

Fortunately for lovers of consistently rising dividends, CSL shares fall into the former category.

What is the growth rate of the CSL dividend?

CSL shares have raised their shareholder income every single year since 2015, bar one. Back in 2015, shareholders enjoyed an annual total of US$1.24 per share. But by 2023, this had risen to US$2.36 per share.

That's following an annual dividend pay rise every single year except 2022. That year, investors enjoyed the same US$2.22 per share that they did in 2021.

Here's what that looks like in visual form:

CSL dividend growthrate
Chart: Author's Own

Over the eight years from 2015 to 2023, CSL's annual dividend rose from US$1.24 per share to US$2.36. This works out to represent an average compounded annual growth rate, and thus dividend growth rate, of 8.38%.

Not something you might assume when looking at the current CSL share price's trailing dividend yield of 1.21%.

Motley Fool contributor Sebastian Bowen has positions in CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Goodman Group. The Motley Fool Australia has recommended CSL and Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A couple sits on the bed in their hotel room wearing white robes, both have seen the bad news on their phones.
Earnings Results

What's going on with ResMed shares today?

The sleep disorder treatment company has released its third-quarter update this morning.

Read more »

A young man sits at his desk working on his laptop with a big smile on his face.
Healthcare Shares

Resmed reports double-digit revenue and profit increases in Q3 FY26

Resmed posted double-digit revenue and profit growth in Q3 FY26, with management confident about continued momentum.

Read more »

a woman puts her fingers in her ears with a pained expression on her face with her eyes closed as though trying to block hearing bad news or an unpleasant loud noise.
Healthcare Shares

Cochlear shares crashed in April, but is a comeback looming?

This ASX 200 healthcare stock is caught between short-term pain and long-term potential.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder, as if giving comfort.
Healthcare Shares

What's making healthcare the worst sector on the ASX 200, down 39% in a year?

An expert outlines the key headwinds weighing on the industry and share prices today.

Read more »

woman testing substance in laboratory dish, csl share price
Healthcare Shares

Good news, falling shares: What's dragging this ASX stock lower?

In biotech, strong updates don't always push the share price higher.

Read more »

A graphic showing a businessman running up a white upwards rising arrow symbolising the soaring Magellan share price today
Healthcare Shares

Guess which ASX All Ords healthcare share is rocketing 18% in Thursday's sinking market

Investors are piling into the ASX healthcare share on Thursday. But why?

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
Healthcare Shares

Mesoblast shares: Cash burn falls and Ryoncil® sales climb

Mesoblast reports higher Ryoncil® sales, improved cash management, and research milestones for the March 2026 quarter.

Read more »

A elder man and woman lean over their balcony with a cuppa, indicating share rpice movement for ASX retirement shares
Healthcare Shares

Regis Healthcare expects FY26 EBITDA to hit top end of guidance

Regis Healthcare expects top-end FY26 earnings as strong occupancy, RAD inflows, and efficiency gains set a positive outlook.

Read more »